Acute lymphoblastic leukaemia in puberty and adolescence

Ann Oncol. 2000 Nov;11(11):1375-9. doi: 10.1023/a:1026538713236.
No abstract available

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Age of Onset
  • Aneuploidy
  • Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Attitude of Health Personnel
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / genetics
  • Case Management
  • Child
  • Child, Preschool
  • Chromosome Aberrations
  • Core Binding Factor Alpha 2 Subunit
  • Drug Resistance, Neoplasm
  • Female
  • Humans
  • Immunophenotyping
  • Infant
  • Male
  • Oncogene Proteins, Fusion / analysis
  • Oncogene Proteins, Fusion / genetics
  • Philadelphia Chromosome
  • Physicians / psychology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / epidemiology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / metabolism
  • Prognosis
  • Puberty
  • Risk Factors
  • Translocation, Genetic
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Core Binding Factor Alpha 2 Subunit
  • Oncogene Proteins, Fusion
  • TEL-AML1 fusion protein